Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells

作者: Pamela J. Maxwell , Jessica Neisen , Johanna Messenger , David J.J. Waugh

DOI: 10.18632/ONCOTARGET.2052

关键词:

摘要: Impaired PTEN function is a genetic hallmark of aggressive prostate cancers (CaP) and associated with increased CXCL8 expression signaling. The current aim was to further characterize biological responses mechanisms underpinning CXCL8-promoted progression PTEN-depleted cancer, focusing on characterizing the potential interplay between other disease-promoting chemokines resident within tumor microenvironment. Autocrine CXCL8-stimulation (i) CXCR1 CXCR2 in PTEN-deficient CaP cells suggesting self-potentiating signaling axis (ii) induced CXCR4 CCR2 PTEN-wild-type cells. In contrast, paracrine secretion CCL2 CXCL12 from stromal WPMY-1 fibroblasts monocytic macrophage-like THP-1 vitro studies demonstrated functional co-operation tumor-derived stromal-derived chemokines. CXCL12-induced migration PC3 CCL2-induced proliferation cancer were dependent upon intrinsic For example, co-culture experiments, CXCL12/CXCR4 but not CCL2/CCR2 supported fibroblast-mediated while underpinned monocyte-enhanced Combined inhibition both more effective inhibiting fibroblast-promoted cell motility repression attenuated CCL2-promoted We conclude that increases sensitivity responsiveness by concurrently upregulating receptor inducing chemokine synthesis. targeting may be required inhibit their multi-faceted actions promoting invasion CaP.

参考文章(31)
DJ Waugh, Catherine Wilson, Angela Seaton, Pamela J Maxwell, Multi-faceted roles for CXC-chemokines in prostate cancer progression Frontiers in Bioscience. ,vol. Volume, pp. 4595- 4604 ,(2008) , 10.2741/3025
Kenneth J. Pienta, Norton S. Taichman, Russell S. Taichman, Laurie K. McCauley, Evan T. Keller, Carlton Cooper, Use of the Stromal Cell-derived Factor-1/CXCR4 Pathway in Prostate Cancer Metastasis to Bone Cancer Research. ,vol. 62, pp. 1832- 1837 ,(2002)
Yu Chen, Ping Chi, Shira Rockowitz, Phillip J Iaquinta, Tambudzai Shamu, Shipra Shukla, Dong Gao, Inna Sirota, Brett S Carver, John Wongvipat, Howard I Scher, Deyou Zheng, Charles L Sawyers, ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss Nature Medicine. ,vol. 19, pp. 1023- 1029 ,(2013) , 10.1038/NM.3216
Alcides Chaux, Sarah B Peskoe, Nilda Gonzalez-Roibon, Luciana Schultz, Roula Albadine, Jessica Hicks, Angelo M De Marzo, Elizabeth A Platz, George J Netto, Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer Modern Pathology. ,vol. 25, pp. 1543- 1549 ,(2012) , 10.1038/MODPATHOL.2012.104
Kenneth L. van Golen, Chi Ying, Linda Sequeira, Cara W. Dubyk, Tracy Reisenberger, Arul M. Chinnaiyan, Kenneth J. Pienta, Robert D. Loberg, CCL2 induces prostate cancer transendothelial cell migration via activation of the small GTPase Rac Journal of Cellular Biochemistry. ,vol. 104, pp. 1587- 1597 ,(2008) , 10.1002/JCB.21652
Seema Singh, Sheng Wu, Michelle Varney, Ajay P. Singh, Rakesh K. Singh, CXCR1 and CXCR2 silencing modulates CXCL8-dependent endothelial cell proliferation, migration and capillary-like structure formation. Microvascular Research. ,vol. 82, pp. 318- 325 ,(2011) , 10.1016/J.MVR.2011.06.011
Robert D. Loberg, LaShon L. Day, Jason Harwood, Chi Ying, Lauren N. St. John, Ryan Giles, Chris K. Neeley, Kenneth J. Pienta, CCL2 is a potent regulator of prostate cancer cell migration and proliferation. Neoplasia. ,vol. 8, pp. 578- 586 ,(2006) , 10.1593/NEO.06280
Gaetano Zafarana, Adrian S. Ishkanian, Chad A. Malloff, Jennifer A. Locke, Jenna Sykes, John Thoms, Wan L. Lam, Jeremy A. Squire, Maisa Yoshimoto, Varune Rohan Ramnarine, Alice Meng, Omar Ahmed, Igor Jurisca, Michael Milosevic, Melania Pintilie, Theo van der Kwast, Robert G. Bristow, Copy number alterations of c‐MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy Cancer. ,vol. 118, pp. 4053- 4062 ,(2012) , 10.1002/CNCR.26729
Lloyd C Trotman, Masaru Niki, Zohar A Dotan, Jason A Koutcher, Antonio Di Cristofano, Andrew Xiao, Alan S Khoo, Pradip Roy-Burman, Norman M Greenberg, Terry Van Dyke, Carlos Cordon-Cardo, Pier Paolo Pandolfi, Pten dose dictates cancer progression in the prostate. PLOS Biology. ,vol. 1, ,(2003) , 10.1371/JOURNAL.PBIO.0000059
Michael C. Haffner, Timothy Mosbruger, David M. Esopi, Helen Fedor, Christopher M. Heaphy, David A. Walker, Nkosi Adejola, Meltem Gürel, Jessica Hicks, Alan K. Meeker, Marc K. Halushka, Jonathan W. Simons, William B. Isaacs, Angelo M. De Marzo, William G. Nelson, Srinivasan Yegnasubramanian, Tracking the clonal origin of lethal prostate cancer Journal of Clinical Investigation. ,vol. 123, pp. 4918- 4922 ,(2013) , 10.1172/JCI70354